Skip to main content
. 2014 Dec 1;24(10):586–589. doi: 10.1089/cap.2013.0108

Table 1.

Cytokines Tested in 45 Subjects Treated with Risperidone

n=45 Pretreatment Mean (SD) Posttreatment Mean (SD) p rho (p)
TGF-β1 well 1 13040.2 (8885.9) 16407.8 (1973.7) 0.09 0.02 (0.91)
TGF-β2 well 2 11412.3 (8711.9) 12794.0 (1485.6) 0.27 0.07 (0.65)
BDNF 1558.4 (292.0) 1256.5 (129.5) 0.86 0.03 (0.83)
Eotaxin 81.9 (41.5) 65.8 (30.2) 0.0003* −0.17 (0.27)
GCSF 43.6 (75.1) 43.8 (66.4) 0.48 −0.08 (0.63)
GMCSF 84.7 (78.0) 82.4 (11.7) 0.60 0.02 (0.88)
IFN-α2 83.1 (202.3) 75.1 (166.8) 0.55 −0.20 (0.20)
IFN-γ 14.1 (20.8) 12.5 (16.1) 0.26 −0.005(0.97)
IL-1α 286.8 (256.4) 292.6 (226.6) 0.90 0.05 (0.76)
IL-1β 2.9 (5.7) 2.5 (4.3) 0.17 0.02 (0.91)
IL-2 4.1 (12.5) 2.9 (8.8) 0.51 0.02 (0.91)
IL-5 2.5 (8.1) 1.8 (4.3) 0.73 −0.001(0.95)
IL-6 5.9 (11.3) 5.9 (12.7) 0.31 0.25 (0.11)
IL-7 27.1 (59.4) 25.8 (54.8) 0.66 −0.14 (0.35)
IL-8 10.3 (17.6) 9.0 (14.2) 0.36 −0.01 (0.93)
IL-10 5.0 (4.4) 5.3 (4.6) 0.50 0.20 (0.21)
IL-12p40 84.4 (102.2) 79.4 (93.5) 0.08 −0.17 (0.28)
IL-12p70 7.2 (12.0) 5.2 (7.9) 0.11 0.07 (0.66)
IL-13 3.0 (9.8) 2.1 (6.7) 0.08 0.16 (0.30)
IL-15 4.9 (11.6) 4.8 (13.0) 0.50 −0.12 (0.46)
IL-17 10.4 (20.3) 8.5 (15.9) 0.19 0.10 (0.53)
IP-10 452.7 (413.2) 444.8 (308.1) 0.95 0.06 (0.72)
MCP-1 313.0 (143.0) 265.7 (80.4) 0.002* 0.11 (0.48)
MIP-1α 46.8 (46.5) 44.0 (39.4) 0.20 0.02 (0.92)
MIP-1β 27.4 (27.3) 25.8 (21.6) 0.64 0.23 (0.15)
TNFα 4.2 (1.6) 4.0 (1.5) 0.09 0.13 (0.42)
TNFβ 6.9 (17.6) 8.6 (25.4) 0.39 −0.01 (0.95)

TGF, transforming growth factor; BDNF, brain-derived neurotrophic factor; GCSF, granulocyte colony-stimulating factor; GMCSF, granulocyte macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; IP, Interferon gamma-induced protein; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor.